CHECKLIST OF KEY FIGURES
for Problems in
Weygandt, Kimmel, & Kieso
FINANCIAL ACCOUNTING, IFRS Edition
2e
ISBN: 978-0-470-9298-4
Problem
No. Check Figures
1-1A (a) Cash, £6,780.
(b) Net income, £3,890.
1-2A (a) Cash, $15,900.
(b) Net income, $4,330; Total assets, $29,800.
1-3A (a) Net income, W 1,800.
(b) Retained earnings, W 1,300.
1-4A (a) Cash, $8,100.
(b) Net income, $4,450.
(c) Total assets $25,800.
1-5A (a) (c) $5,000 (e) $62,000 (g) $120,000
(k) 220,000.
(b) Retained earnings, $7,000.
1-1B (a) Cash, €11,500.
(b) Net income, €5,600.
1-2B (a) Cash, $2,600.
(b) Net income, $3,440; Total assets, $14,100.
1-3B (a) Net income, ¥2,500.
Total assets, ¥41,000.
1-4B (a) Cash, $13,700; (b) Net income, $3,200; (c) Total assets, $17,800.
1-5B (a) (c) $7,000 (e) $38,000 (g) $129,000
(k) $225,000.
(b) Retained earnings, $5,000.
BYP1-1 (a) 2010: W 134,288,744million.
(d) 2010: W 154,630,328million.
BYP1-2 2. CHF12,083 (Nestlé).
4. £4,482 (Zetar).
BYP1-4 (b) Total assets, $21,900.
(d) Revenues earned, $4,700.
BPY1-5 Total assets, £39,500.
2-2A (c) Trial balance totals, €28,400.
2-3A (d) Trial balance totals, $63,000.
2-4A Trial balance totals, £26,720.
2-5A (d) Trial balance totals, €35,180.
2-2B (c) Trial balance totals, $53,000.
2-3B (c) Trial balance totals, £93,160.
2-4B Trial balance totals, $16,348.
2-5B (d) Trial balance totals, $64,150.
BYP2-4 (c) Correct net income, $6,040.
3-1A (c) Adj. trial balance totals, $40,750.
3-2A (c) Adj. trial balance totals, €280,325.
(d) Net income, €17,475; Retained earnings, €12,475; Total assets, €203,275.
3-3A (b) Net income, $38,450; Retained earnings, $31,950; Total assets, $69,000.
3-4A 2. Rent Revenue, $74,000.
3-5A (d) Trial balance, £33,350.
(f) Adj. trial balance, £33,890.
(g) Net income £1,660; Total assets, £26,860.
3-6A (b) Adj. trial balance, $111,155.
(c) Net income, $16,025; Total assets, $68,875.
3-1B (c) Adj. trial balance, R$34,000.
3-2B (c) Adj. trial balance, $99,875.
(d) Net income, $6,675; Total assets, $91,705.
3-3B (b) Net income, CHF4,850; Retained earnings, CHF3,850; Total assets, CHF40,925.
3-4B 2. Rent revenue, £84,000.
3-5B (d) Trial balance, $29,300.
(f) Adj. trial balance, $29,850.
(g) Net income, $1,930; Total assets, $23,200.
BYP3-2 (a) £1,697,000 (Zetar)
(b) CHF1,018,000,000 (Nestlé).
(d) CHF23,591,000,000 (Nestlé).
BYP3-4 (a) Net income, $26,415.
4-1A (a) Adj. trial balance, €58,650.
(b) Net income, €7,920; Total assets, €49,970.
4-2A (a) Net income, $22,500.
(b) Total current assets, $38,900.
(e) Post-closing trial balance, $84,900.
4-3A (a) Retained earnings, $3,900.
(d) Post-closing trial balance, $48,500.
4-4A (a) Adj. trial balance, R$489,700.
(b) Total assets, R$205,300.
(e) Post-closing trial balance, R$247,500.
4-5A (c) Adj. trial balance, $27,270.
(d) Net income, $3,810.
(g) Post-closing trial balance, $22,230.
4-6A (b) Trial balance, £22,570.
4-1B (a) Adj. trial balance, $21,330.
(b) Net income, $3,300; Total assets, $15,470.
4-2B (a) Net income, £9,200.
(b) Total current assets, £19,600.
(e) Post-closing trial balance, £46,600.
4-3B (a) Retained earnings, $29,600.
(d) Post-closing trial balance, $50,500.
4-4B (a) Adj. trial balance, £407,400.
(b) Total assets, £288,300.
(e) Post-closing trial balance, £294,900.
4-5B (c) Adj. trial balance, $47,100.
(d) Net income, $8,000.
(g) Post-closing trial balance, $36,700.
Comprehensive Problem
(c) Adj. trial balance, $30,730.
(d) Net income, $2,900;
Total assets, $25,330.
(g) Post-closing trial balance, $25,530.
BYP4-1 (a) 2010: W 54,211,297million.
(e) 2010: W 39,944,721million.
BYP4-2 (a)2. £16,583 (Zetar).
4. CHF62,598 (Nestlé).
BYP4-4 (a) Total assets, $72,700; Retained earnings,
$14,330.
5-2A (c) Gross profit, €6,765.
5-3A (a) Net income, $128,500; Total assets, $456,100.
5-4A (c) Trial balance, ¥6,130.
5-5A Gross profit, $295,300.
5-6A (a) 2013 COGS, $146,600.
(c) 2013 Ending A/P, $15,000.
5-7A (c) Trial balance, CHF6,448; Gross profit, CHF855.
5-8A (a) Adj. trial balance, $981,200.
(b) Income from operations, $2,020; Total assets, $181,520.
(e) Post-closing trial balance, $216,020.
5-2B (c) Gross profit, $2,567.
5-3B (a) Net income, £30,900; Total assets, £207,300.
5-4B (c) Trial balance, $5,540.
5-5B Gross profit, $402,300.
5-6B (c) $6,700; (g) $15,200; (1) $2,100.
5-7B (c) Trial balance, €8,448; Gross profit, €397.
BYP5-1 (b) Gross profit rate: 2010 33.6%.
(c) Net income to sales: 2010 10.4%.
BYP5-2 (a)(1) £27,321 (Zetar).
(2) 58.2% (Nestlé).
(3) £6,723 (Zetar).
(4) 3.2% (Nestlé).
BYP5-4 (a) (1) Net income, $56,400.
(2) Net income, $55,000.
(c) Net income, $83,700.
6-2A (a) Total cost, $116,500.
(b) FIFO (1) $32,000; (2) $84,500.
6-3A (b) Ave Cost (1) £4,975, (2) £14,925.
6-4A (a) FIFO ending inventory, $39,750; Net income,
$106,386.
6-5A (1) FIFO (i) €1,260, (iii) €3,470.
6-6A (b) Gross profit, $164,100.
6-7A (a) FIFO net income, £93,600.
6-8A (1) Ave Cost (i) $7,584, (iii) $8,266.
6-9A (a) (1) FIFO, $740; (2) Ave cost, $702.
6-10A (a) Gross profit rate, 40%.
(b) Estimated inventory lost, €44,940.
6-11A (a) Sporting Goods, $56,700.
Jewelry, $32,500.
6-2B (a) Total cost, £149,500.
(b) FIFO (1) £32,000, (2) £117,500.
6-3B (b) Ave cost (1) $7,710, (2) $17,990.
6-4B (a) FIFO ending inventory, €40,500 ; Net income, €124,160.
6-5B (a) Total cost, $10,975.
(1) FIFO (i) $4,430, (iii) $4,605.
6-6B (a) FIFO gross profit, $4,080.
6-7B (a) FIFO net income, CHF109,480.
6-8B (2) Ave cost (i) $2,908, (iii) $2,452.
6-9B (1) FIFO, HK$882; (2) Ave cost, HK$852.
6-10B (a) Gross profit rate, 42%.
(b) Estimated inventory lost, $28,500.
6-11B (a) Hardcovers, €512,000.
Paperbacks, €247,500.
BYP6-1 (a) 2010: W 13,364,524M.
(d) 2010: 66.4%.
BYP6-2 1. 6.6 times (Zetar).
62 days (Nestlé).
BYP6-4 (b) 2013 gross profit, $216,000.
7-3A (a) Adj. balance per books, £9,044.50.
7-4A (a) Adj. balance per books, $15,458.40.
7-5A (a) Adj. balance per books, €23,354.
7-3B (a) Adj. balance per books, $14,307.
7-4B (a) Adj. balance per books, R$7,201.
7-5B (a) Adj. balance per books, $17,421.
7-6B (a) Adj. balance per books, £17,623.31.
BYP7-2 (a)(1) £4,282 Thousands (Zetar).
(2) CHF13,608 M (Nestlé).
8-1A (b) Accounts receivable, R$1,325,000.
8-2A (c) Bad debt expense, £64,900.
8-3A (a) Bad debt expense, $32,730.
8-4A (b) Bad debt expense, HK$10,370.
8-5A (b) (1) Bad debt expense, $10,950.
8-6A (c) Total receivables, $30,015.
8-1B (b) Accounts receivable, $312,000.
8-2B (c) Bad debt expense, $21,830.
8-3B (a) Bad debt expense, $40,250.
8-4B (b) Bad debt expense, CHF8,240.
8-5B (b) (1) Bad debt expense, $15,200.
8-6B (c) Total receivables, €56,390.
BYP8-1 (b) Bad debt expense, $12,930.
BYP8-2 (1) 9.0 times (Nestlé).
(2) 60.8 days (Zetar).
BYP8-4 (a) 2014: $17,800, 3.56%.
(b) 2014: $19,800 3.96%.
9-1A Land, €164,400.
9-2A (b) (1) $52,500, (2) $43,750.
9-3A (a) (2) Annual depreciation, R$6,400.
9-4A 2014 depreciation, $9,600.
9-5A (b) Depreciation – buildings, €530,000; equipment, €3,995,000.
9-6A (c) Gain on disposal, $3,000.
9-7A (c) Total intangible assets, $203,500.
9-9A (a) .60 times (Luō).
9-1B Land, $124,200.
9-2B (b) (2) ¥26,000.
9-3B (a) (2) Annual depreciation, $13,000.
9-4B 2014 depreciation, £7,200.
9-5B (b) Depreciation – buildings, $570,000, equipment, $2,960,000.
9-6B (b) Gain on disposal, €13,000.
9-7B (c) Total intangible assets, $347,250.
9-9B (a) 1.10 times (Nina).
Comprehensive Problem:
(c) Net income, $68,256.
(d) Total assets, $271,996.
BYP9-1 (a) Book value, W 52,964,594.
BYP9-2 (a) 1.52 times (Zetar).
BYP9-4 (a) Givens accumulated depreciation, $57,000;
Runge accumulated depreciation, $106,640.
10-1A (c) Total current liabilities, £74,448.
10-2A (c) Carrying value of note, $15,075.
(d) Interest, $1,075.
10-3A (d) Interest expense, CHF16,800.
10-4A (c) Loss on bond redemption, $4,000.
10-5A (c) Current liabilities 12/31/14, R$59,276.
10-6A (c) Bonds Payable, $22,819.
10-7A (b) Carrying value of bonds, €3,397,066.
(c) (1) Interest expense-2015, $338,602.
10-8A (d) Carrying value of bonds, $2,064,000.
10-9A (c) Carrying value of bonds, Rs3,085,500.
10-10A (c) Gain on bond redemption, $56,400.
10-1B (c) Total current liabilities, ¥66,893.
10-2B (d) Interest expense, $40,000.
10-3B (c) Loss on bond redemption, R$5,400.
10-4B (c) Current liabilities, 12/31/14, $28,156.
10-5B (c) Bonds Payable, £10,269.
10-6B (b) Carrying value of bonds, $4,274,244.
(c) (1) Interest expense, $214,666.
10-7B (d) Carrying value of bonds, ¥4,865,000.
10-8B (c) Carrying value of bonds, $6,108,000.
10-9B (c) Loss on bond redemption, €52,500.
Comprehensive Problem 1:
(c) Net income, $61,880; Total assets, $252,950.
Comprehensive Problem 2:
(a) Total assets, CHF885,225 (Eastland).
BYP10-1 (c) Non-current liabl increase, W 64,769million.
BYP10-2 (b) (1) £5,196 (Zetar).
(d) (1) 43.9% (Nestlé).
BYP10-4 (a) Carrying value of bonds, 1/1/14,
$2,342,400.
11-1A (c) Total share capital, HK$16,650,000.
11-2A (b) Treasury shares, $9,000.
(c) Total equity, $726,000.
11-3A (c) Total equity, €5,370,000.
11-4A (c) Total equity, $2,196,400.
11-5A (c) Total equity, €5,229,000.
11-6A (b) Total equity, $2,806,000.
11-7A (c) Total equity, £1,566,000.
11-8A (a) Total equity, $3,282,400.
11-9A Total equity, CHF2,304.
11-1B (c) Total share capital, $1,235,000.
11-2B (b) Treasury shares, £10,500.
(c) Total equity, £1,073,300.
11-3B (c) Total equity, $2,234,500.
11-4B (c) Total equity, €1,779,000.
11-5B (b) Total equity, $28,875,000.
11-6B (c) Total equity, R$6,840,000.
11-7B (a) Total equity, $6,403,000.
BYP11-1 (c) 2010: 129,843,077 shares.
BYP11-2 (a) £35.1 (Zetar).
(b) 60.9% (Nestlé).
12-1A (a) Gain on Sale, HK$60,000.
12-2A (b) Unrealized loss, $800.
12-3A (b) Unrealized loss, £4,100.
(c) Total equity, £2,495,900.
12-4A (a) Total dividend revenue, $54,000.
(b) Revenue from investments, $96,000.
12-5A (c) Unrealized loss, R$6,280.
(d) Investments, R$183,200.
12-6A Total assets, $2,791,000.
12-7A (b) Eliminations, ¥1,225,000.
(c) Total equity, ¥3,002,000.
12-1B (a) Gain on Sale, $28,000.
12-2B (b) Unrealized loss, $2,020.
12-3B (b) Unrealized loss, $6,300.
(c) Total equity, $3,193,700.
12-4B (a) Total dividend revenue, $40,000.
(b) Revenue from investments, $120,000.
12-5B (c) Unrealized loss, €3,240.
(d) Investments, €122,400.
12-6B Total assets, CHF4,290,000.
12-7B (b) Eliminations, $710,000.
(c) Total equity, $2,490,000.
Comprehensive Problem:
(b) Earnings per share- D.F., $1.97.
(c) (2) Total Shares Issued, 165,000.
(e) (2) Investment balance, $979,740.
BYP12-2 (a) 2. £3,789 (Zetar).
13-2A (a) Net income, $77,200.
13-3A Net cash provided by operating activities, €1,215,000.
13-4A Cash receipts from customers, €7,300,000.
13-5A Net cash provided by operating activities, $311,000.
13-6A Net cash provided by operating activities, $311,000.
13-7A Net cash provided by operating activities, £29,300.
13-8A Cash payments to suppliers, £171,000.
13-9A Net cash provided by operating activities, $184,350.
13-10A Cash payments for operating expenses, $16,210.
13-11A Net cash provided by operating activities, R$108,520.
13-12A Total reconciling items, 580,910.
13-2B Cash proceeds, €21,000.
13-3B Net cash provided by operating activities, $1,185,000.
13-4B Cash payments to suppliers, $3,380,000.
13-5B Net cash provided by operating activities, £127,000.
13-6B Net cash provided by operating activities, £127,000.
13-7B Net cash used by operating activities, $(5,000).
13-8B Cash payments to suppliers, $236,000.
13-9B Net cash provided by operating activities
€94,700.
13-10B Cash payments for operating expenses, € 23,400.
13-11B Net cash provided by operating activities, $75,400.
BYP13-1 (f) Interest W 582,292M; Taxes W 2,135,287M.
BYP13-2 (a) £ (3,036) (Zetar).
BYP13-5 (a) Net loss, ($44,000).
14-1 (a) Net income (Lionel) 9.5%; (Barrymore) 3.9%.
14-2 (c) Return on assets, 21.3%.
(e) Acid-test ratio, 1.15:1.
(g) Inventory turnover, 8.9 times.
(i) Asset turnover, 2.0 times.
14-3 (a) 2013 - Asset turnover, 1.1 times; Price- earnings ratio, 4.9 times; Payout ratio, 62.5%.
14-4 (a) 2013: Acid test, 1.1:1; Receivables turnover, 9.6 times; Profit margin, 5.0%; Asset turnover, 1.3 times.
(b) 1. 2014: 11.2% 2. 2014: 34.6%.
14-5 (a) Target - (1) 1.7:1, (3) 35.4, (5) 58.9, (7) 1.5 times, (9) 18.9%, (11) 6.9.
14-6 (b) Acid-test ratio, 0.93:1.
(c) Receivables turnover, 6.3 times.
(e) Profit margin ratio, 7.3%.
(k) Payout ratio, 37.3%.
14-7 Gross profit, $3,790,500; Interest expense,
$218,000; Total assets, $7,725,000; Total liabilities, $4,325,000.
P14-8 Net income, €3,010,000.
P14-9 Net income, $188,300.
BYP14-1 (b) (1) 2010: profit margin, 10.4%.
(2) 2010: asset turnover, 1.25 times.
(3) 2010: return on assets, 13.1%.
(4) 2010: return on ordinary shareholders’ equity, 19.9%.
(c) (1) 2010: debt to total assets, 33.5%.
(2) 2010: times interest earned, 3.5 times.
BYP14-2 (1). (i) 2.3% (Zetar).
(ii) 2.0% (Nestlé).
(2). (i) 9.3% (Zetar).
(ii) 16.7% (Nestlé).
BEE-1 (b) FV=$16,162.74.
BEE-4 FV=$1,012,196.40.
BEE-6 FV=$51,426.55.
BEE-9 PV=$472,627.50.
BEE-11 PV=$393,736.08.
BEE-13 PV of principal=$113,067.
BEE-15 PV of interest=$12,785.03.
BEE-16 PV=$2,208,698.
BEE-19 PV of future cash flows=$115,309.
BEE-21 9 years.
BEE-23 7 payments.
BEE-27 (a) PV = $86,530.07
PF-1A (a) Net pay, $1,756.11.
(b) Payroll tax expense, $302.22.
(d) Cash paid, $509.86.
PF-2A (b) Payroll tax expense, $6,398.70.
PF-3A (a) Salaries and wages payable, $266,240.
(b) Payroll tax expense, $39,070.
PF-1B (a) Net pay, $1,874.39.
(b) Payroll tax expense, $336.96.
(d) Cash paid, $612.24.
PF-2B (b) Payroll tax expense, $7,008.20.
PF-3B (a) Salaries and wages payable, $266,717.
(b) Payroll tax expense, $42,108.
BYPF-2 (a) Temporary, $56,448.
Permanent, $63,552.
PG-1A (a) Balancing totals, €21,815.
PG-2A (a) Balancing totals, $13,250.
(c) Accounts payable, $1,900.
PG-3A (a) Purchases journal – Accounts payable cr., $23,890; Sales journal totals, $17,030; $11,921.
(c) Accounts receivable, $16,965.
Accounts payable, $23,590.
PG-4A Sales journal total, R$22,530.
Purchases journal total, R$31,100.
Cash receipts journal balancing total, R$30,640.
Cash payments journal balancing total, R$42,880.
PG-5A (b) Sales journal total, $20,100.
Cash receipts journal balancing total, $101,850.
(e) Trial balance totals, $120,220.
(h) Adj. Trial balance totals,$120,220.
PG-6A (b) Cash receipts journal balancing total, €54,200.
Cash payments journal balancing total, €21,750.
(d) Trial balance totals, €138,250.
(e) Accounts receivable, €18,600.
Accounts payable, €13,150.
PG-1B (a) Balancing totals, £31,540.
PG-2B (a) Balancing totals, $15,590.
(c) Accounts payable, $2,150.
PG-3B (a) Purchases journal - Accounts payable Cr.,
TL38,660; Sales journal totals, TL11,900; TL7,735.
(c) Accounts receivable, TL11,660.
Accounts payable, TL37,760.
PG-4B Sales journal total, $23,030.
Purchases journal total, $39,500.
Cash receipts journal balancing total, $72,770.
Cash payments journal balancing total, $54,720.
PG-5B (b) Purchases journal total, €44,800.
Cash payments journal balancing total, € 46,220.
(e) Trial balance totals, €70,600.
(h) Adj. trial balance totals, €70,760.
PH-1A (c) Current liabilities, €68,888.
PH-2A (b) Capital lease - $62,000.
PH-1B (c) Current liabilities, £82,746.
PH -2B (c) Capital lease - $38,000.